BBIO
USDBridgeBio Pharma Inc. Common Stock
Prix en Temps Réel
Graphique des Prix
Métriques Clés
Métriques de Marché
Ouverture
$61.420
Haut
$61.905
Bas
$60.230
Volume
2.10M
Fondamentaux de l'Entreprise
Capitalisation Boursière
11.8B
Industrie
Biotechnologie
Pays
United States
Statistiques de Trading
Volume Moyen
2.63M
Bourse
NMS
Devise
USD
Intervalle sur 52 Semaines
Actualités Connexes
BridgeBio to Participate in November Investor Conferences
PALO ALTO, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (NASDAQ:BBIO) ("BridgeBio" or the "Company"), a new type of biopharmaceutical company focused on genetic diseases, today announced that
BridgeBio to Present Data from the Overall ATTR-CM Variant and V142I (V122I) Populations from ATTRibute-CM at the AHA Scientific Sessions 2025
PALO ALTO, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (NASDAQ:BBIO) ("BridgeBio" or the "Company"), a new type of biopharmaceutical company focused on genetic diseases, announced today that ten
HC Wainwright & Co. Reiterates Buy on BridgeBio Pharma, Maintains $90 Price Target
HC Wainwright & Co. analyst Raghuram Selvaraju reiterates BridgeBio Pharma with a Buy and maintains $90 price target.
Goldman Sachs Maintains Buy on BridgeBio Pharma, Raises Price Target to $100
Goldman Sachs analyst Paul Choi maintains BridgeBio Pharma with a Buy and raises the price target from $55 to $100.
TD Cowen Maintains Buy on BridgeBio Pharma, Raises Price Target to $95
TD Cowen analyst Tyler Van Buren maintains BridgeBio Pharma with a Buy and raises the price target from $60 to $95.
Raymond James Reiterates Outperform on BridgeBio Pharma, Raises Price Target to $71
Raymond James analyst Martin Auster reiterates BridgeBio Pharma with a Outperform and raises the price target from $69 to $71.
Cantor Fitzgerald Maintains Overweight on BridgeBio Pharma, Raises Price Target to $110
Cantor Fitzgerald analyst Josh Schimmer maintains BridgeBio Pharma with a Overweight and raises the price target from $100 to $110.
Actions Connexes
PAR
PAR Technology Corporation
GIPR
Generation Income Properties Inc.
MEDP
Medpace Holdings Inc.
GJS
Goldman Sachs Group Securities STRATS Trust for Goldman Sachs Group Securities Series 2006-2
PYCR
Paycor HCM Inc.
Restez Informé
Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.